Z-0198-2024Class II

RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser Catalog Number: RX4040

Name: Z-0198-2024 RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser Catalog Number: RX4040
Creator: Randox Laboratories Ltd.
Published: 2023-09-06
License: https://open.fda.gov/license/

Randox Laboratories, Limited / initiated 2023-09-06 / Open, Classified

FDA source

Randox Laboratories Ltd. began a recall of RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser Catalog Number: RX4040 on 2023-09-06. FDA classified it as Class II and gives the reason as "RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature...". As of 2026-09-10, the recall status on record is Open, Classified.

Recall record

Recall number: Z-0198-2024
Classification: Class II
Status: Open, Classified
Initiated: 2023-09-06
Posted: 2023-10-31
Recalling firm: Randox Laboratories, Limited
Product: RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser Catalog Number: RX4040
Product code: CGA Glucose Oxidase, Glucose
Reason for recall: RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature conditions when incorrectly. Potential to report incorrectly.
FDA root cause: Under Investigation by firm
Action: Randox issued Medical Device Correction letter (REC687) on 9/13/23 to to US and PR customers on 9/12/23. Letter states reason for recall, health risk and action to take: Randox recommendations: " Auto rerun settings are disabled, see Appendix A for guidance for each Rx instrument. " Results with flag(<) reported as the bottom of the technical range. Sample Volume settings Low should not be applied. " Results with flag (>) reported as the top of the technical range. Sample Volume settings high and dilutions should not be applied. A manual dilution should be performed, and results multiplied by the dilution factor. The RX Parameter rerun settings will be updated with a parameter release in due course, the Instructions For Use will also be updated at this time. Action to be taken: " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to [email protected] within five working days. Transmission of Field Safety Notice: Send a copy of the FSN to all affected customers and to those who need to be aware within your organisation.
Quantity in commerce: 5 units
Distribution: US Nationwide distribution including Puerto Rico
Product codes and lots: GTIN: 05055273207774 Lot/ Batch Number (1) Lot/ Batch Number 7241-0551 7241-0545 7241-0531 7241-0317 7241-0219

Enforcement reports

One row per recalled product line

FDA enforcement reports joined to recall event Z-0198-2024
Recall number	Class	Status	Voluntary or mandated	Report date	Classified
Z-0198-2024	Class II	Ongoing	Voluntary: Firm initiated	2023-11-08	2023-10-31
Z-0199-2024	Class II	Ongoing	Voluntary: Firm initiated	2023-11-08	2023-10-31
Z-0200-2024	Class II	Ongoing	Voluntary: Firm initiated	2023-11-08	2023-10-31
Z-0201-2024	Class II	Ongoing	Voluntary: Firm initiated	2023-11-08	2023-10-31
Z-0202-2024	Class II	Ongoing	Voluntary: Firm initiated	2023-11-08	2023-10-31

Product code CGA

K024014Class IIRandox Rx DaytonaRandox Laboratories, Ltd. / cleared 2003-12-04

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device recall database and the FDA enforcement reports, both ingested from openFDA. The recall record supplies the product, the reason and the product code; the enforcement report supplies the classification. The two datasets are exported by FDA on different days, and the date above is the older of the two, so nothing on this page is newer than it says.

MDM adds the root cause tag, derived from FDA’s own root cause text, and the cross-links to the product code, the clearances named on the record and MDM coverage. Where a recall has not been joined to an enforcement report, no classification is shown.

Data as of 2026-09-30, the FDA export date for this dataset. Page last changed 2026-09-05. View this recall on fda.gov (opens on fda.gov)